Dr James Bond on Biomark
Dr James Bond on Biomark
BioMark CEO Interview with SNNLive, Sep 2015
Stock News Now Interview In this SNNLive On-Location, our host spoke with Rashid Ahmed, President and CEO of BioMark Diagnostics Inc. (OTCQB: BMKDF) in New York City, NY.
BioMark Diagnostics presents at Rodman & Renshaw Conference in NY, USA
BioMark Diagnostics Inc. presents at Rodman & Reshaw Conference in New York, USA Follow these links for our audio presentation and corporate overview power point. Audio Presentation Powerpoint Presentation
Quest for Game Changing Lung Cancer Diagnostic Assay
HealthTech Innovation Hub and Surrey Memorial Hospital Rashid Ahmed, President & CEO Dr. James Bond, Chief of Thoracic Surgery, Surrey Memorial Hospital
BioMark Diagnostics to open U.S. headquarters in Maryland.
News and Events – 8/13/15 TOP STORY: Emergent Receives $44M from CDC Gaithersburg’s Emergent BioSolutions will receive $44M from the CDC in support of its role in the supply of VIGIV, a therapeutic licensed by FDA for the treatment of complications due to smallpox vaccination. Emergent also announced its plans to spin-off its […]
New cancer strategy ‘could save thousands’ of lives
By Smitha Mundasad Health reporter, BBC News About 5,000 lives could be saved each year in England if GPs follow new guidelines on cancer diagnosis, the health watchdog NICE says. Its experts say that a new approach is necessary to tackle England’s lagging cancer survival rates. The guidelines suggest all GPs order certain tests directly, […]
Cancer Cases Projected to Rise 40% in 15 Years as Population Ages, Grows
About half of cancer cases can be prevented with healthy behaviours and policies WATCH CBC: http://www.cbc.ca/news/health/cancer-cases-projected-to-rise-40-in-15-years-as-population-ages-grows-1.3088717 New cancer cases are expected to increase by about 40 per cent by 2030 as the population ages and grows, the Canadian Cancer Society says. The society released its annual cancer statistics on Wednesday to provide long-term predictions on […]
BioMark and Response to Treatment
BioMark’s Principal Engineer attended the World Congress on Interventional Oncology (WCIO) May 6th – 9th in New York to discuss BioMark’s Response to Treatment program and how it would fit into the rapidly developing interventional oncology market place. BioMark’s Principal Engineer spent the month of March in Japan, Taiwan and China to explore the opportunity […]
Florida Cancer Specialists Foundation – Havana Night
Florida Cancer Specialists Foundation – Havana Night BioMark’s team recently travelled to Florida for “Havana Night” hosted by Florida Cancer Specialists Foundation. It was an inspirational evening meeting leading oncologists who help cancer patients in need with their living expenses while undergoing treatment. It enables those fighting cancer to concentrate on recovering rather than focus […]
Criterion BioScience provides coverage for BioMark Diagnostics in USA
For full article and market brief, please go to http://criterionbioscience.com/biomark-diagnostics/
